Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL EYE DROP COMPOSITION FOR TREATING DRY EYE SYNDROME CONTAINING REBAMIPIDE AND METHOD FOR SOLUBILIZING AND STABILIZING SAME
Document Type and Number:
WIPO Patent Application WO/2019/059479
Kind Code:
A1
Abstract:
The present invention relates to an eye drop composition for treating dry eye syndrome, characterized in that the eye drop composition remains stable during storage without precipitation occurring and contains a safe ingredient for use as an eye drop, by solubilizing rebamipide that is a poorly soluble compound, and a method for producing the same. The eye drop composition for treating dry eye syndrome of the present invention includes a base for solubilizing rebamipide, and is characterized by containing a stabilizer for maintaining a supersaturated stabilized state, a specific type of buffer for maintaining biocompatible pH of 7 to 8 and an osmotic agent. A method for producing the same comprises the steps of: adding a base to rebamipide or a pharmaceutically acceptable salt thereof and a stabilizer and dissolving the same in water to obtain an aqueous eye drop solution of pH of 10 to pH of 11; adding at least one osmotic agent selected from a buffer and a nonionic osmotic agent to the eye drop solution and dissolving the same; and after adjusting the pH to 7 to 8 with an acid, filtering the solution with a syringe filter to make the same sterile. The produced eye drop is in the form of an aqueous solution, is stable when frozen, refrigerated, and at room temperature, and includes a therapeutic agent for dry eye syndrome which is stable even when cross-stored in a refrigerator or at room temperature, or at a refrigerating temperature or room temperature.

More Like This:
Inventors:
JEON SUN-DUCK (KR)
HWANG SUNG-WOO (KR)
YOON SI-YEOL (KR)
CHO KWAN-HYUNG (KR)
KIM JAE-YEOL (KR)
JI YOUNG-HOON (KR)
Application Number:
KR2018/003300
Publication Date:
March 28, 2019
Filing Date:
March 21, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
DAEWOO PHARMACEUTICAL IND CO LTD (KR)
International Classes:
A61K9/00; A61K31/4704; A61K47/26; A61K47/38
Domestic Patent References:
WO2008074853A12008-06-26
Foreign References:
KR20070092965A2007-09-14
JP2015531338A2015-11-02
JP2016179960A2016-10-13
KR101692578B12017-01-03
Attorney, Agent or Firm:
HANSUNG INTELLECTUAL PROPERTY (KR)
Download PDF: